Search

everythinglearnresearchcommunity

for

Search:↓

Jute leaves may help reduce DHT levels, potentially aiding in conditions like hair loss and prostate issues.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Enzymatic synthesis improved the water solubility of the flavonoid baicalin, which may help treat hair loss conditions.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Postmenopausal women often experience hair loss on the scalp and increased facial hair, but iron supplements may not help.

The document concludes that scientists created various steroids with different properties, including a more effective semi-synthetic vitamin D.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

PCOS may increase the risk of mental health issues like depression and anxiety.

Androgens may increase arrhythmias in Brugada Syndrome, while Finasteride could reduce them.

Hormones significantly affect skin health, with vitamin D playing a key role.

Local estrogen synthesis in skin may improve wound healing.

Ageing and increased senescent cells significantly contribute to common hair loss.

The Ar/miR-221/IGF-1 pathway is involved in male pattern baldness, with miR-221 potentially being a new target for treatment.

Six new risk spots for early hair loss were found, which also link to Parkinson's disease and lower fertility. Two genes, FOXA2 and HDAC4, could be new treatment targets. Hair loss might also be connected to heart disease, metabolic syndrome, and prostate cancer.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

Poria cocos polysaccharides and finasteride both help treat chronic nonbacterial prostatitis, but Poria cocos polysaccharides also improve gut health.

Androgenetic alopecia causes hair loss, affects men more severely, and treatments are only temporarily effective.

An integrative approach combining medical, nutritional, and lifestyle changes effectively manages female pattern hair loss.

Androgens reduce macrophage receptor expression, affecting immune response, while antiandrogens counteract this effect.

Cyproterone acetate is an effective treatment for women with acne, hair loss, and excessive hair growth.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Hormonal therapies are safe and effective for treating adult women's acne.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.